Friday, 11 May 2018
BLUEFISH PHARMACEUTICALS EXPANDS EUROPEAN FOOTPRINT WITH OFFICE OPENING IN IRELAND
Founded in Sweden, with its long tradition of industrial entrepreneurship, Bluefish Pharmaceuticals is a company that strive to make quality medicines accessible to more people.
Bluefish, is pleased to announce that we are opening our own Sales and Marketing office in Dublin, Ireland in the month of May.
This is a part of Bluefish growth plan to strengthen the footprint in Europe. Bluefish has an established presence in the Irish market through our previous distribution partner and are already familiar to Irish market needs. Bluefish currently conducts operations in 13 countries in Europe, and over the next few years, will also strengthen our presence in Europe with the aim of becoming a strong European company.
The sales office will be run by Keith Hynes, General Manager, Ireland.
“I am proud to launch our Irish operations during the month of May 2018. Bluefish have a wealth of experience working within the generics market place. We have continuity of supply in all our products and a simple procurement procedure. Continuity of supply is a big challenge in the Irish market right now, so we have made this a priority at Bluefish and a solid commitment of promise to our customers. Bluefish will launch 40 products over the coming 18 months which will add to our existing 20 products. We are very excited to bring our model to the Irish market and are looking forward to working with pharmacies across the country. Bluefish will bring quality medicines with continuity of supply accessible to the widest diaspora”
About Bluefish Pharmaceuticals
Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of approximately 80 products and is growing.